TY - JOUR
T1 - Event-related potentials to rare visual targets and negative symptom severity in a transdiagnostic psychiatric sample
AU - Salgari, Giulia C.
AU - Potts, Geoffrey F.
AU - Schmidt, Joseph
AU - Chan, Chi C.
AU - Spencer, Christopher C.
AU - Bedwell, Jeffrey S.
N1 - Funding Information:
This work was supported by the National Institute of Mental Health (1R15MH097222-01A1; PI: J.S. Bedwell) and matching funds from University of Central Florida College of Sciences and Office of Research and Commercialization.
Publisher Copyright:
© 2021 International Federation of Clinical Neurophysiology
PY - 2021/7
Y1 - 2021/7
N2 - Objectives: Negative psychiatric symptoms are often resistant to treatments, regardless of the disorder in which they appear. One model for a cause of negative symptoms is impairment in higher-order cognition. The current study examined how particular bottom-up and top-down mechanisms of selective attention relate to severity of negative symptoms across a transdiagnostic psychiatric sample. Methods: The sample consisted of 130 participants: 25 schizophrenia-spectrum disorders, 26 bipolar disorders, 18 unipolar depression, and 61 nonpsychiatric controls. The relationships between attentional event-related potentials following rare visual targets (i.e., N1, N2b, P2a, and P3b) and severity of the negative symptom domains of anhedonia, avolition, and blunted affect were evaluated using frequentist and Bayesian analyses. Results: P3b and N2b mean amplitudes were inversely related to the Positive and Negative Syndrome Scale-Negative Symptom Factor severity score across the entire sample. Subsequent regression analyses showed a significant negative transdiagnostic relationship between P3b amplitude and blunted affect severity. Conclusions: Results indicate that negative symptoms, and particularly blunted affect, may have a stronger association with deficits in top-down mechanisms of selective attention. Significance: This suggests that people with greater severity of blunted affect, independent of diagnosis, do not allocate sufficient cognitive resources when engaging in activities requiring selective attention.
AB - Objectives: Negative psychiatric symptoms are often resistant to treatments, regardless of the disorder in which they appear. One model for a cause of negative symptoms is impairment in higher-order cognition. The current study examined how particular bottom-up and top-down mechanisms of selective attention relate to severity of negative symptoms across a transdiagnostic psychiatric sample. Methods: The sample consisted of 130 participants: 25 schizophrenia-spectrum disorders, 26 bipolar disorders, 18 unipolar depression, and 61 nonpsychiatric controls. The relationships between attentional event-related potentials following rare visual targets (i.e., N1, N2b, P2a, and P3b) and severity of the negative symptom domains of anhedonia, avolition, and blunted affect were evaluated using frequentist and Bayesian analyses. Results: P3b and N2b mean amplitudes were inversely related to the Positive and Negative Syndrome Scale-Negative Symptom Factor severity score across the entire sample. Subsequent regression analyses showed a significant negative transdiagnostic relationship between P3b amplitude and blunted affect severity. Conclusions: Results indicate that negative symptoms, and particularly blunted affect, may have a stronger association with deficits in top-down mechanisms of selective attention. Significance: This suggests that people with greater severity of blunted affect, independent of diagnosis, do not allocate sufficient cognitive resources when engaging in activities requiring selective attention.
KW - Event-related potentials
KW - Mood disorders
KW - Negative symptoms
KW - Schizophrenia-spectrum disorders
KW - Selective attention
KW - Transdiagnostic
UR - http://www.scopus.com/inward/record.url?scp=85106959283&partnerID=8YFLogxK
U2 - 10.1016/j.clinph.2021.02.398
DO - 10.1016/j.clinph.2021.02.398
M3 - Article
C2 - 34030054
AN - SCOPUS:85106959283
VL - 132
SP - 1526
EP - 1536
JO - Clinical Neurophysiology
JF - Clinical Neurophysiology
SN - 1388-2457
IS - 7
ER -